Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | CES2 | O00748 | 2/20 | 0.46 |
| ▸ | CES1 | P23141 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 3/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10699004 | 0.82 | LMNA (0.62) | ALDH1A1LMNASRD5A2RAB9ANPC1 | |
| SCHEMBL52200 | 0.80 | ALDH1A1 (1.00) | ALDH1A1LMNASRD5A2RAB9ACES2 | |
| SCHEMBL822185 | 0.80 | ALDH1A1 (1.00) | ALDH1A1LMNASRD5A2RAB9ACES2 | |
| SCHEMBL24186223 | 0.80 | LTA4H (0.52) | ALDH1A1LMNARAB9ANPC1CES2 | |
| SCHEMBL24186221 | 0.79 | NPSR1 (0.58) | ALDH1A1LMNARAB9ANPC1CES2 | |
| SCHEMBL14143387 | 0.79 | ALDH1A1 (0.50) | ALDH1A1LMNASRD5A2RAB9ANPC1 | |
| SCHEMBL4516770 | 0.79 | ALDH1A1 (0.61) | ALDH1A1LMNASRD5A2RAB9ANPC1 | |
| SCHEMBL11528213 | 0.78 | ALDH1A1 (0.94) | ALDH1A1LMNASRD5A2RAB9ACES2 | |
| Hydrochloric Acid SCHEMBL27909743 | 0.78 | ALDH1A1 (0.94) | ALDH1A1LMNASRD5A2RAB9ACES2 | |
| SCHEMBL15662997 | 0.77 | ALDH1A1 (0.65) | ALDH1A1LMNASRD5A2RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10930926-B2 | Nonaqueous electrolyte secondary battery and cathode sheet therefor | NITTO DENKO CORPORATION (JP) | 2021-02-23 | — | — | US | disclosed |
| CN-105958011-B | Nonaqueous electrolyte secondary battery and positive electrode sheet for same | 日东电工株式会社 | 2020-07-03 | — | — | CN | disclosed |
| US-20170317345-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY AND CATHODE SHEET THEREFOR | NITTO DENKO CORPORATION (JP) | 2017-11-02 | — | — | US | disclosed |
| US-9735423-B2 | Nonaqueous electrolyte secondary battery and cathode sheet therefor | NITTO DENKO CORPORATION (JP) | 2017-08-15 | — | — | US | disclosed |
| EP-3057170-B1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY AND CATHODE SHEET THEREFOR | NITTO DENKO CORP (JP) | 2017-04-26 | — | — | EP | disclosed |
| EP-3057170-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY AND CATHODE SHEET THEREFOR | Nitto Denko Corporation (JP) | 2016-08-17 | — | — | EP | disclosed |
| EP-2728659-B1 | NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY AND POSITIVE-ELECTRODE SHEET THEREFOR | NITTO DENKO CORP (JP) | 2016-02-24 | — | — | EP | disclosed |
| US-20140220438-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY AND CATHODE SHEET THEREFOR | NITTO DENKO CORPORATION (JP) | 2014-08-07 | — | — | US | disclosed |
| EP-2728659-A1 | NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY AND POSITIVE-ELECTRODE SHEET THEREFOR | Nitto Denko Corporation (JP) | 2014-05-07 | — | — | EP | disclosed |
| EP-1647546-B1 | NOVEL HETEROARYL DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO (JP) | 2012-05-02 | — | — | EP | disclosed |
| EP-1837329-A1 | NOVEL HETEROARYL DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2007-09-26 | — | — | EP | disclosed |
| US-7220773-B2 | Heterocylic amines used as antidiabetic or hyperglycemic agents | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-05-22 | — | — | US | disclosed |
| US-7220773-B2 | Heterocylic amines used as antidiabetic or hyperglycemic agents | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-05-22 | — | — | US | disclosed |
| US-7220773-B2 | Heterocylic amines used as antidiabetic or hyperglycemic agents | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-05-22 | — | — | US | disclosed |
| US-20060194857-A1 | Novel heteroaryl derivative | DAINIPPON SUMITOMO PHARMA CO. LTD. (JP) | 2006-08-31 | — | — | US | disclosed |
| EP-1647546-A1 | NOVEL HETEROARYL DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2006-04-19 | — | — | EP | disclosed |
| US-20050227978-A1 | Fibrosis inhibitor | SUMITOMO PHARMACEUTICALS CO., LTD. (JP) | 2005-10-13 | — | — | US | disclosed |
| US-20040209939-A1 | Pyrrole derivatives | SUMITOMO PHARMACEUTICALS CO., LTD. | 2004-10-21 | — | — | US | disclosed |
| US-20040162331-A1 | Pyrrole derivative | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2004-08-19 | — | — | US | disclosed |
| EP-1386913-A1 | PYRROLE DERIVATIVE | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2004-02-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050227978-A1 | Fibrosis inhibitor | SMAD3, MMP1, SMAD2 | ALDH1A1 476/4885LMNA 4536/4885SRD5A2 371/4885 |
| US-20060194857-A1 | Novel heteroaryl derivative | NR0B1, UGT1A10, NR0B2 | ALDH1A1 552/4885LMNA 3906/4885SRD5A2 43/4885 |
| US-20040162331-A1 | Pyrrole derivative | SLC5A1, GLP1R, SLC5A2 | ALDH1A1 548/4885LMNA 4783/4885SRD5A2 164/4885 |
| US-20040209939-A1 | Pyrrole derivatives | NCOA1, PKD1, NCOR1 | ALDH1A1 530/4885LMNA 4564/4885SRD5A2 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.